Skip to content

Clinical trials

Active, not recruiting Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Active, not recruiting Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20121
20131
20141
20162
20171
20183
20191
20205
20212
20223
20237
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Astellas Pharma Global Development, Inc.2
AstraZeneca2
Ruijin Hospital2
UNICANCER2
Alliance for Clinical Trials in Oncology1
Antelope Surgical Solutions, Inc1
Boston Scientific Corporation1
Bristol-Myers Squibb1
Centre Hospitalier Universitaire Vaudois1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma34
Carcinoma, Non-Small-Cell Lung8
Stomach Neoplasms7
Neoplasms6
Carcinoma4
Pancreatic Neoplasms4
Carcinoma, Squamous Cell3
Esophageal Neoplasms3
Neoplasm Metastasis3
Prostatic Neoplasms3

Trials

Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.